DNA Delivery Systems for Gene Therapies
Dr. Vivienne Raper has written an excellent FutureLab/Biocompare editorial comparing the various...
Dr. Vivienne Raper has written an excellent FutureLab/Biocompare editorial comparing the various...
The FDA has approved 12 gene therapies so far, and the agency's top drug regulator wants to see the...
Munich, Germany, February 23, 2022 – SIRION Biotech GmbH is proud to announce our achievement of...
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy
...
Munich, October 8, 2021: The French Ministry of Higher Education, Research and Innovation have...
Solutions to complement Company’s growing position in cell and gene therapy research and development
Bavarian trio unite for French round-the-world sailing race: NanoTemper and SIRION Biotech support...
SIRION Biotech is now part of the Revvity portfolio!
SIRION Biotech licences its LentiBOOST® transduction technology to Cellectis
AAV Webinar
On Demand
CAR-TCR Summit
August 29 - September 1, Boston
Meet Benjamin Eberhardt, LentiBOOST Product Manager! Eberhardt@sirion-biotech.com
Japan Society of Cell and Gene Therapy
September 11 - September 13, Osaka
BIOJapan
October 11 - October 13, Yokohama